Abstract
Intradermal influenza vaccination has been studied for more than 80 y. The revived interest in this strategy of vaccination is a result of the innovative technologies in needle design allowing more precise injection and making the device easier to use. Furthermore, clinical trials on these novel devices have demonstrated significant dose sparing effects, improved immunogenicity and very few adverse effects. This review compares intradermal vaccination with various devices with subcutaneous and intramuscular vaccination. We also discussed the role of topical adjuvant before intradermal vaccination.
| Original language | English |
|---|---|
| Pages (from-to) | 565-570 |
| Number of pages | 6 |
| Journal | Human Vaccines and Immunotherapeutics |
| Volume | 14 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - Mar 4 2018 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2018 Taylor & Francis.
ASJC Scopus Subject Areas
- Immunology and Allergy
- Immunology
- Pharmacology
Keywords
- adjuvant
- influenza
- intradermal
- vaccination